A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

Armed with new clinical trial results, Amgen is expanding studies of its KRAS inhibitor Lumakras in pancreatic cancer, as it tries to extend the label for the first-in-class drug beyond its ...

The American designer worked for Tadashi Shoji, Tahari and Perry Ellis among others, and had his own namesake company at one ...

It was a busy week in the biotech sector, marked by significant regulatory and pipeline updates. Among these, shares of ...

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...

ChatGPT Plus (Premium), free for students, is finally available, and it's the academic plot twist no one could have predicted that too just in time for finals.

The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.

Lower testosterone can lead to a range of health issues, including lower sex drive, impotence, loss of muscle and ...

Ask a Doctor is new series of physician-authored columns offering insights and advice on common health topics. It is not a ...

PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis ...

Take one capsule daily, preferably with a full meal and a glass of water. For best results, take Gluco6 consistently for 30 ...